Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance
Hypoxia, an oxygen-deprived condition of the tumor, is one of the major reasons for resistance to chemotherapy. Carbonic anhydrases are generally involved in pH homeostasis in normal conditions, but in solid tumors having a strong relation with hypoxia, the carbonic anhydrase IX (CA-IX) enzyme is ov...
Main Authors: | Muhammad Umair Amin, Sajid Ali, Muhammad Yasir Ali, Dominik C. Fuhrmann, Imran Tariq, Benjamin S. Seitz, Eduard Preis, Jana Brüßler, Bernhard Brüne, Udo Bakowsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2022.2092234 |
Similar Items
-
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
by: Justina Kazokaitė, et al.
Published: (2017-11-01) -
Ultrasound-Responsive Smart Drug Delivery System of Lipid Coated Mesoporous Silica Nanoparticles
by: Muhammad Umair Amin, et al.
Published: (2021-09-01) -
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma
by: An-Ping Xiang, et al.
Published: (2022-08-01) -
Carbonic Anhydrase IX as a Marker of Disease Severity in Obstructive Sleep Apnea
by: Ayşegül Altıntop Geçkil, et al.
Published: (2022-11-01) -
Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice
by: Xue Zhang, et al.
Published: (2019-09-01)